Erythromycin A 11,12-carbonate and method of use
US4681872A · kind A · utility
3Cited by
3References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 12, 1985 |
| Grant date | Jul 21, 1987 |
| Priority date | — |
| Expiry date | Nov 12, 2005 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H17/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
An erythromycin A derivative with high antimicrobial activity and improved pharmacokinetics is disclosed. 4"-Deoxyerythromycin A 11,12-carbonate and derivatives show superior in vitro and in vivo antimicrobial activity compared to erythromycin A, and when administered to animals has a serum half-life much prolonged over that of erythromycin A.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.